NICE Guidelines

GUIDELINES : NICE

Vibegron for treating symptoms of overactive bladder syndrome

Faculty Name:

GUIDELINES : NICE

Ublituximab for treating relapsing multiple sclerosis

Faculty Name:

GUIDELINES : NICE

Transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraine

Faculty Name:

GUIDELINES : NICE

Tenecteplase for treating acute ischaemic stroke

Faculty Name:

GUIDELINES : NICE

Suspected neurological conditions – recognition and referral

Faculty Name:

GUIDELINES : NICE

Rimegepant for treating migraine

Faculty Name:

GUIDELINES : NICE

Rimegepant for preventing migraine

Faculty Name:

GUIDELINES : NICE

Phrenic nerve pacing for ventilator-dependent high cervical spinal cord injury

Faculty Name:

GUIDELINES : NICE

Omaveloxolone for treating Friedreich’s ataxia in people 16 years and over (terminated appraisal)

Faculty Name:

GUIDELINES : NICE

MRI-guided focused ultrasound thalamotomy for treating moderate to severe tremor in Parkinson’s

Faculty Name:

GUIDELINES : NICE

MRI-guided focused ultrasound subthalamotomy for treating Parkinson’s

Faculty Name:

GUIDELINES : NICE

Headaches in over 12s diagnosis and management

Faculty Name:

GUIDELINES : NICE

Ganaxolone for treating seizures caused by CDKL5 deficiency disorder in people 2 years and over

Faculty Name:

GUIDELINES : NICE

Fremanezumab for preventing migraine

Faculty Name:

GUIDELINES : NICE

Foslevodopa–foscarbidopa for treating advanced Parkinson’s with motor symptoms

Faculty Name:

GUIDELINES : NICE

Fenfluramine for treating seizures associated with Lennox–Gastaut syndrome in people 2 years and over

Faculty Name:

GUIDELINES : NICE

Fenfluramine for treating seizures associated with Dravet syndrome

Faculty Name:

GUIDELINES : NICE

Epilepsies in children, young people and adults

Faculty Name:

GUIDELINES : NICE

Devices for remote monitoring of Parkinson’s disease

Faculty Name:

GUIDELINES : NICE

Dementia – assessment, management and support for people living with dementia and their carers

Faculty Name:

GUIDELINES : NICE

Dabrafenib with trametinib for treating BRAF V600E mutation positive glioma in children and young people aged 1 year and over

Faculty Name:

GUIDELINES : NICE

CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack

Faculty Name:

GUIDELINES : NICE

Cladribine for treating active relapsing forms of multiple sclerosis

Faculty Name:

GUIDELINES : NICE

Cerebral palsy in adults

Faculty Name:

GUIDELINES : NICE

Cenobamate for treating focal onset seizures in epilepsy

Faculty Name:

GUIDELINES : NICE

Cannabidiol for treating seizures caused by tuberous sclerosis complex

Faculty Name:

GUIDELINES : NICE

Atogepant for preventing migraine

Faculty Name:

GUIDELINES : NICE

Artificial intelligence (AI)-derived software to help clinical decision making in stroke

Faculty Name:

NICE Guidelines

Vibegron for treating symptoms of overactive bladder syndrome

Ublituximab for treating relapsing multiple sclerosis

Transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraine

Tenecteplase for treating acute ischaemic stroke

Suspected neurological conditions – recognition and referral

Rimegepant for treating migraine

Rimegepant for preventing migraine

Phrenic nerve pacing for ventilator-dependent high cervical spinal cord injury

Omaveloxolone for treating Friedreich’s ataxia in people 16 years and over (terminated appraisal)

MRI-guided focused ultrasound thalamotomy for treating moderate to severe tremor in Parkinson’s

MRI-guided focused ultrasound subthalamotomy for treating Parkinson’s

Headaches in over 12s diagnosis and management

Ganaxolone for treating seizures caused by CDKL5 deficiency disorder in people 2 years and over

Fremanezumab for preventing migraine

Foslevodopa–foscarbidopa for treating advanced Parkinson’s with motor symptoms

Fenfluramine for treating seizures associated with Lennox–Gastaut syndrome in people 2 years and over

Fenfluramine for treating seizures associated with Dravet syndrome

Epilepsies in children, young people and adults

Devices for remote monitoring of Parkinson’s disease

Dementia – assessment, management and support for people living with dementia and their carers

Dabrafenib with trametinib for treating BRAF V600E mutation positive glioma in children and young people aged 1 year and over

CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack

Cladribine for treating active relapsing forms of multiple sclerosis

Cerebral palsy in adults

Cenobamate for treating focal onset seizures in epilepsy

Cannabidiol for treating seizures caused by tuberous sclerosis complex

Atogepant for preventing migraine

Artificial intelligence (AI)-derived software to help clinical decision making in stroke

Quick Links

Legal

Contact